You are here: Industry Insights > aspirin

News List

Can aspirin treat Alzheimer’s? biospectrumasia
July 04, 2018
A study shows low-dose aspirin may aid removal of harmful amyloid plaque in the brain…
Aspirin may block bowel tumour formation europeanpharmaceuticalreview
June 11, 2018
Researchers have shed light on how taking aspirin can help to prevent bowel cancer. They found that the painkiller blocks a key process linked to tumour formation…
Daily aspirin linked to higher risk in men worldpharmanews
May 07, 2018
Men who take once-daily aspirin have nearly double the risk of melanoma compared to men who are not exposed to daily aspirin,
Aspirin lowers risk of death for patients with diabetes and heart failure europeanpharmaceuticalreview
March 01, 2018
Researchers assess aspirin as a preventive measure for patients who have both diabetes and heart failure…
Bayer files low-dose Xarelto/aspirin combo pharmatimes
November 08, 2017
Bayer is seeking permission to market in Europe its bloodthinner Xarelto in combination with aspirin to reduce the risk of cardiovascular events in patients with coronary or peripheral artery disease.
Aspirin may be a cost-effective alternative to fillings pharmafile
September 11, 2017
Researchers from Queen University, Belfast, have discovered that aspirin may be able to reverse the effects of tooth decay.
Snake venom may replace aspirin biospectrumasia
June 14, 2017
The team designed a molecule based on the structure of trowaglerix to block GPVI activity. It prevented platelets from clotting when it was mixed with blood.
Johnson & Johnson, Bayer's Xarelto superior to aspirin for long-term prevention of recurrent blood c drugs.com
March 20, 2017
Results from the Phase III EINSTEIN CHOICE study presented at the American College of Cardiology (ACC) annual scientific session demonstrated that extended use of Johnson & Johnson and Bayer's anticoagulant Xarelto (rivaroxaban)...
Drugs similar to aspirin, ibuprofen could help treat sepsis, study suggests worldpharmanews
February 24, 2017
A potentially life-saving treatment for sepsis has been under our noses for decades in the non-steroidal anti-inflammatory drugs (NSAIDs) most people have in their medicine cabinets, a new University of Colorado Boulder study suggests.
An alternative theory on how aspirin may thwart cancer worldpharmanews
February 10, 2017
Studies abound that point to a role for plain old aspirin in keeping deadly cancers at bay. While aspirin is not yet part of mainstream treatment for any cancer, it is recommended by the U.S. Preventive Services Task Force for certain adults to help preve

Previous page 1 2 3 4 5 6 Next page